TORONTO, August 10, 2010 – Dalradian Resources Inc. (“Dalradian” or the “Company”) (TSX: DNA, DNA.WT) has closed its initial public offering of 22,700,000 units (the “Units”) of the Company at a price of C$1.50 per Unit for aggregate gross proceeds of C$34,050,000 (the “Offering”). Each Unit consists of one common share (a “Common Share”) of the Company and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”). Each Warrant entitles the holder to acquire one common share of the Company at an exercise price of C$2.25 until August 10, 2011. The Company has granted to the agents an over-allotment option to purchase up to an additional 3,405,000 Units, exercisable until September 9, 2010, to cover over-allotments, if any, and for market stabilization purposes. If such option is exercised in full, aggregate gross proceeds of the Offering will be C$39,157,500.

The Common Shares and the Warrants are listed on the Toronto Stock Exchange under the symbols "DNA" and “DNA.WT,” respectively, and will start trading today.

GMP Securities L.P. and Dundee Securities Corporation co-led the syndicate, which included Clarus Securities Inc. and Cormark Securities Inc.

The offer and sale of the securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an exemption from the registration requirements of the U.S. Securities Act. This news release does not constitute an offer to sell or the solicitation of an offer to buy the securities in the United States.

For further information, please contact:
Annemarie Brissenden Director, Investor and Corporate Relations
Telephone: 416.572.2299
Email: investor@dalradian.com

- 30 -